4.6 Article

The Paucity of Evidence Supporting Screening for Stages 1-3 CKD in Asymptomatic Patients with or without Risk Factors

期刊

出版社

AMER SOC NEPHROLOGY
DOI: 10.2215/CJN.02940314

关键词

-

资金

  1. Agency for Healthcare Research and Quality
  2. US Department of Veterans Affairs
  3. National Kidney Foundation
  4. International Kidney Foundation

向作者/读者索取更多资源

The American College of Physicians recently published a guideline on screening for CKD that recommends against screening for CKD in asymptomatic adults without risk factors. The generally accepted criteria for population-based screening for disease state that screening should improve important clinical outcomes while limiting harms for those individuals screened. However, CKD screening does not meet these criteria. There is currently no evidence evaluating or demonstrating benefits for providing early treatment for patients identified via screening who do not have risk factors. On the other hand, harms are associated with the screening and include false-positive results, unnecessary testing and treatment, and disease labeling.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据